Pages that link to "Q36369598"

The following pages link to Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A (Q36369598):

Displaying 29 items.

• Viral vectors as vaccine platforms: from immunogenicity to impact (Q24574798) (← links)
• Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens (Q26750912) (← links)
• Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85A (Q36096965) (← links)
• Replacing, reducing and refining the use of animals in tuberculosis vaccine research (Q38964310) (← links)
• TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development (Q42372774) (← links)
• Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane (Q47607706) (← links)
• Next-Generation Vaccines Based on Bacille Calmette-Guérin. (Q49829375) (← links)
• The current status, challenges, and future developments of new tuberculosis vaccines. (Q52337140) (← links)
• Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application. (Q52657152) (← links)
• Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine. (Q54234703) (← links)
• Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine (Q58553770) (← links)
• Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4 T cell population following BCG immunisation (Q58762751) (← links)
• Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection (Q59349879) (← links)
• Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine (Q64374656) (← links)
• Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus (Q64374730) (← links)
• Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity. (Q64990202) (← links)
• Tuberculosis vaccine development: from classic to clinical candidates (Q89724634) (← links)
• Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology (Q90345218) (← links)
• A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults (Q91311589) (← links)
• Immunology of Mycobacterium tuberculosis Infections (Q91820033) (← links)
• An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction (Q91959357) (← links)
• Inactivated Lactobacillus plantarum Carrying a Surface-Displayed Ag85B-ESAT-6 Fusion Antigen as a Booster Vaccine Against Mycobacterium tuberculosis Infection (Q92239476) (← links)
• Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges (Q92246549) (← links)
• Identification of antigens presented by MHC for vaccines against tuberculosis (Q92463453) (← links)
• Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice (Q92622099) (← links)
• Tuberculosis vaccine candidates based on mycobacterial cell envelope components (Q92857461) (← links)
• Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells (Q93184501) (← links)
• Respiratory Immunization With a Whole Cell Inactivated Vaccine Induces Functional Mucosal Immunoglobulins Against Tuberculosis in Mice and Non-human Primates (Q97067599) (← links)
• Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma (Q101133235) (← links)